Baumgartner Jeffrey W 4
4 · CIRRUS LOGIC, INC. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Cirrus Logic (CRUS) EVP Jeffrey Baumgartner Exercises Options and Sells 1,458 Shares
What Happened
Jeffrey W. Baumgartner, EVP of R&D at Cirrus Logic, exercised 1,458 stock options on July 1, 2026, paying $68.56 per share (total cost $99,960). The same 1,458 shares were then sold in an open-market transaction at $145.97 per share for total gross proceeds of $212,824. The Form 4 also records the derivative conversion (the option being exercised) associated with this transaction.
Key Details
- Transaction date: July 1, 2026. Filing date: July 2, 2026 (timely).
- Option exercise: 1,458 shares at $68.56/share = $99,960 (Transaction code M).
- Open-market sale: 1,458 shares at $145.97/share = $212,824 (Transaction code S).
- Derivative conversion entry: 1,458 shares reported as disposed at $0 (reflects the option conversion/exercise).
- Footnotes: Transaction executed under a Rule 10b5-1 trading plan adopted Feb 27, 2026 (F1). The options were fully vested (original vesting completed 11/6/23) (F2).
- Shares owned after the transaction: not disclosed in the provided filing data.
- Not reported as a late filing.
Context
This was essentially a cashless exercise followed immediately by an open-market sale: Baumgartner paid the option strike to convert options into shares, then sold those shares. The use of a 10b5-1 plan indicates the sale was prearranged and not necessarily a reaction to recent company news. Such exercises-and-sales are common for executives monetizing vested options and do not by themselves indicate a change in company outlook.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-07-01$68.56/sh+1,458$99,960→ 17,863 total - Sale
Common Stock
[F1]2026-07-01$145.97/sh−1,458$212,824→ 16,405 total - Exercise/Conversion
Incentive Stock Option (right to buy)
[F1][F2]2026-07-01−1,458→ 0 totalExercise: $68.56Exp: 2029-11-06→ Common Stock (1,458 underlying)
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 27, 2026.
- [F2]Only vested shares can be exercised under this option. 25% of the shares vested on 11/6/20; the remaining shares vested monthly over the following 36months so that the option was fully vested and exercisable on 11/6/23.